These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 22480310
21. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Shao J, Li X, Lu X, Jiang C, Hu Y, Li Q, You Y, Fu Z. Colloids Surf B Biointerfaces; 2009 Aug 01; 72(1):40-7. PubMed ID: 19395246 [Abstract] [Full Text] [Related]
22. Protective effect of resveratrol against oxidative stress in cholestasis. Ara C, Kirimlioglu H, Karabulut AB, Coban S, Ay S, Harputluoglu M, Kirimlioglu V, Yilmaz S. J Surg Res; 2005 Aug 01; 127(2):112-7. PubMed ID: 16083749 [Abstract] [Full Text] [Related]
23. Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation. Vitaglione P, Ottanelli B, Milani S, Morisco F, Caporaso N, Fogliano V. J Gastroenterol Hepatol; 2009 Apr 01; 24(4):618-22. PubMed ID: 18823437 [Abstract] [Full Text] [Related]
27. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ, Belvisi MG. FASEB J; 2005 May 30; 19(7):840-1. PubMed ID: 15734790 [Abstract] [Full Text] [Related]
29. The research on the anti-inflammatory activity and hepatotoxicity of triptolide-loaded solid lipid nanoparticle. Mei Z, Li X, Wu Q, Hu S, Yang X. Pharmacol Res; 2005 Apr 30; 51(4):345-51. PubMed ID: 15683748 [Abstract] [Full Text] [Related]
30. Resveratrol and liver disease: from bench to bedside and community. Bishayee A, Darvesh AS, Politis T, McGory R. Liver Int; 2010 Sep 30; 30(8):1103-14. PubMed ID: 20557453 [Abstract] [Full Text] [Related]
31. Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl4 in rats: role of TGF-beta modulation and oxidative stress. Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P. Fundam Clin Pharmacol; 2008 Aug 30; 22(4):417-27. PubMed ID: 18705752 [Abstract] [Full Text] [Related]
32. Rat liver mitochondrial damage under acute or chronic carbon tetrachloride-induced intoxication: protection by melatonin and cranberry flavonoids. Cheshchevik VT, Lapshina EA, Dremza IK, Zabrodskaya SV, Reiter RJ, Prokopchik NI, Zavodnik IB. Toxicol Appl Pharmacol; 2012 Jun 15; 261(3):271-9. PubMed ID: 22521486 [Abstract] [Full Text] [Related]
33. Oral administration of diphenyl diselenide potentiates hepatotoxicity induced by carbon tetrachloride in rats. Nogueira CW, Borges LP, Souza AC. J Appl Toxicol; 2009 Mar 15; 29(2):156-64. PubMed ID: 18989868 [Abstract] [Full Text] [Related]
35. Administration of resveratrol: What formulation solutions to bioavailability limitations? Amri A, Chaumeil JC, Sfar S, Charrueau C. J Control Release; 2012 Mar 10; 158(2):182-93. PubMed ID: 21978644 [Abstract] [Full Text] [Related]